Description
Brentuximab vedotin: an innovative treatment for patients with Hodgkin and systemic anaplastic large cell lymphoma
- You cannot add another "Article: Highlights in digestive oncology" to your cart. View cart
Article: Brentuximab vedotin: an innovative treatment for patients with Hodgkin and systemic anaplastic large cell lymphoma
€2.42
Related products
-
Article: Highlights in respiratory oncology
€2.42 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart
